Endothelial-binding, proinflammatory T cells identified by MCAM (CD146) expression: Characterization and role in human autoimmune diseases
Authors:
- 1 May 2015
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 14 (5) , 415-422
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute of NIH
This publication has 53 references indexed in Scilit:
- Targeting interleukin-17 in patients with active rheumatoid arthritis: rationale and clinical potentialTherapeutic Advances in Musculoskeletal Disease, 2013
- Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNSScientific Reports, 2013
- MCAM-expressing CD4+ T cells in peripheral blood secrete IL-17A and are significantly elevated in inflammatory autoimmune diseasesJournal of Autoimmunity, 2011
- Characterization and In Vivo Testing of Mesenchymal Stem Cells Derived from Human Embryonic Stem CellsTissue Engineering Part A, 2011
- CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localizationBlood, 2011
- CD146+ T lymphocytes are increased in both the peripheral circulation and in the synovial effusions of patients with various musculoskeletal diseases and display pro‐inflammatory gene profilesCytometry Part B: Clinical Cytometry, 2009
- Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cellsJournal of Experimental Medicine, 2008
- A Prescription for Human ImmunologyImmunity, 2008
- Multiple Differentiation Capacity of STRO-1 + /CD146 + PDL Mesenchymal Progenitor CellsStem Cells and Development, 2008
- Wnt5a Control of Cell Polarity and Directional Movement by Polarized Redistribution of Adhesion ReceptorsScience, 2008